Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Birkmayer

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Wiener Klinische Wochenschrift|May 11, 1979
[The combined treatment of Parkinson's disease with L-dopa plus decarboxylase inhibitors (carbidopa, benserazide) (author's transl)]F Podiwinsky, M Mentasti, P Riederer, et al.
Advances in Neurology|January 1, 1975
Dopaminergic supersensitivity in parkinsonismW Birkmayer, W Danielczyk, E Neumayer, et al.
Acta Psychiatrica Scandinavica|July 6, 2017
4-HYDROXY-3-METHOXYPHENYLGLYCOL AS AN INDEX OF BRAIN NORADRENALINE TURNOVER IN ENDOGENOUS DEPRESSIONP Riederer, W Birkmayer, D Seemann, et al.
Journal of Neural Transmission|January 1, 1973
L-dopa level in plasma, primary condition for the kinetic effectW Birkmayer, W Danielcyk, E Neumayer, et al.
Journal of Neural Transmission|January 1, 1974
Nucleus ruber and L-dopa psychosis: biochemical post-mortem findingsW Birkmayer, W Danielczyk, E Neumayer, et al.
Journal of Neural Transmission|January 1, 1983
DL-3,4-threo-DOPS in Parkinson's disease: effects on orthostatic hypotension and dizzinessW Birkmayer, G Birkmayer, H Lechner, et al.
Journal of Neural Transmission|January 1, 1984
L-deprenyl plus L-phenylalanine in the treatment of depressionW Birkmayer, P Riederer, W Linauer, et al.
Deutsche Medizinische Wochenschrift (1946)|May 17, 1974
[Statistical aspects of the tyrosine-tryptophan diagram in depression (author's transl)]L Ambrozi, P Riederer, W Birkmayer, et al.
Advances in Biochemical Psychopharmacology|January 1, 1978
Monoamine oxidase activity during (--)-deprenil therapy: human brain post-mortem studiesP Riederer, M B Youdim, W Birkmayer, et al.
British Journal of Pharmacology|November 1, 1976
L-dopa and (-)-deprenil in the treatment of Parkinson's disease: a long-term study [proceedings]L Ambrozi, W Birkmayer, P Riederer, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Wiener Klinische Wochenschrift|May 11, 1979
[The combined treatment of Parkinson's disease with L-dopa plus decarboxylase inhibitors (carbidopa, benserazide) (author's transl)]F Podiwinsky, M Mentasti, P Riederer, et al.
Advances in Neurology|January 1, 1975
Dopaminergic supersensitivity in parkinsonismW Birkmayer, W Danielczyk, E Neumayer, et al.
Acta Psychiatrica Scandinavica|July 6, 2017
4-HYDROXY-3-METHOXYPHENYLGLYCOL AS AN INDEX OF BRAIN NORADRENALINE TURNOVER IN ENDOGENOUS DEPRESSIONP Riederer, W Birkmayer, D Seemann, et al.
Journal of Neural Transmission|January 1, 1973
L-dopa level in plasma, primary condition for the kinetic effectW Birkmayer, W Danielcyk, E Neumayer, et al.
Journal of Neural Transmission|January 1, 1974
Nucleus ruber and L-dopa psychosis: biochemical post-mortem findingsW Birkmayer, W Danielczyk, E Neumayer, et al.
Journal of Neural Transmission|January 1, 1983
DL-3,4-threo-DOPS in Parkinson's disease: effects on orthostatic hypotension and dizzinessW Birkmayer, G Birkmayer, H Lechner, et al.
Journal of Neural Transmission|January 1, 1984
L-deprenyl plus L-phenylalanine in the treatment of depressionW Birkmayer, P Riederer, W Linauer, et al.
Deutsche Medizinische Wochenschrift (1946)|May 17, 1974
[Statistical aspects of the tyrosine-tryptophan diagram in depression (author's transl)]L Ambrozi, P Riederer, W Birkmayer, et al.
Advances in Biochemical Psychopharmacology|January 1, 1978
Monoamine oxidase activity during (--)-deprenil therapy: human brain post-mortem studiesP Riederer, M B Youdim, W Birkmayer, et al.
British Journal of Pharmacology|November 1, 1976
L-dopa and (-)-deprenil in the treatment of Parkinson's disease: a long-term study [proceedings]L Ambrozi, W Birkmayer, P Riederer, et al.
Pageof 8